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Filamentous actinomycetes are commercially widely used as producers of natural products (in particular
antibiotics) and of industrial enzymes. However, the mycelial lifestyle of actinomycetes, resulting in highly
viscous broths and unfavorable pellet formation, has been a major bottleneck in their commercialization. Here
we describe the successful morphological engineering of industrially important streptomycetes through con-
trolled expression of the morphogene ssgA. This led to improved growth of many industrial and reference
streptomycetes, with fragmentation of the mycelial clumps resulting in significantly enhanced growth rates in
batch fermentations of Streptomyces coelicolor and Streptomyces lividans. Product formation was also stimulated,
with a twofold increase in yield of enzyme production by S. lividans. We anticipate that the use of the presented
methodology will make actinomycetes significantly more attractive as industrial and sustainable production
hosts.
The exponential increase in the global demand for natural
products and bulk chemicals effects an increasing burden on
the environment, necessitating more sustainable fermentation
technologies (6). Filamentous microorganisms are widely used
as industrial producers of products such as antibiotics, antican-
cer agents, antifungicides, and enzymes (2, 8, 12). These or-
ganisms include the eukaryotic filamentous fungi (ascomy-
cetes) and the prokaryotic actinomycetes (e.g., Amycolatopsis,
Nocardia, and Streptomyces). The market capitalizations for
antibiotics and enzymes total around 28 and 2 billion dollars
per year, respectively. The study of genome sequences of ac-
tinomycetes has unveiled a surprisingly large number of cryptic
antibiotic biosynthesis clusters, thus offering new challenges
for directed drug discovery (11). A novel screening technique
established that selective growth conditions can induce the
normally dormant biosynthetic clusters for enediyne-type an-
titumor antibiotics (25). In contrast to unicellular microorgan-
isms such as Escherichia coli, Bacillus spp., and Saccharomyces
cerevisiae, filamentous microbes are highly heteromorphous
and are therefore less favorable production organisms. The
mycelial lifestyle of actinomycetes results in production pro-
cesses that are typically characterized by a complex rheology
(1, 7, 10). This results in mass-related mechanical stress, in
heat transfer problems, and in oxidative stress (16, 17). The
consequential problems related to filamentous growth include
(i) slow growth rates and highly viscous cultures, (ii) large
mycelial clumps that are mainly physiologically active around
the edge of the clump (pellet), with significant oxygen and
nutrient transfer problems towards the center, (iii) mixing re-
quirements that necessitate high stirrer speeds, resulting in
uncontrolled fragmentation and lysis of the mycelium, and (iv)
complex and therefore expensive downstream processing.
While enzymes from actinomycetes are often produced in an
industrially preferred host (plug-bug approach), other enzymes
and (almost) all antibiotics can only be synthesized by the
natural producer. For antibiotics this is primarily due to the
complexity of the biosynthesis clusters (12), and for proteins it
is due to the actinomycete-specific sorting sequences that are
not recognized by other bacterial secretion systems (9). Better
understanding of factors that control growth and morphology
is therefore a prerequisite for the optimization of production
processes. In-depth studies by Bushell and colleagues on eryth-
romycin production by Saccharopolyspora erythraea showed a
striking correlation between the diameter of the mycelium
fragments and productivity (7). Interestingly, selection of vari-
ants with reduced branching rates and enhanced strength of
the cell wall resulted in a significantly enhanced production
(23). It is unclear how these observations translate to other
production processes (e.g., enzymes), as antibiotic production
is often strongly growth phase dependent (4). The molecular
mechanisms underlying morphology of actinomycetes in liq-
uid-grown cultures are only poorly understood. However, at
least one important factor is SsgA, a member of a novel family
of actinomycete-specific proteins with six or seven members in
streptomycetes that relate functionally to cell division and mor-
phogenesis (18). The SsgA-like proteins appear to be primarily
involved in the control of peptidoglycan maintenance. It was
shown that the growth behavior of streptomycetes in sub-
merged cultures depends in part on the expression level of
ssgA, whereby enhanced SsgA protein levels result in mycelial
fragmentation (14, 21, 22).
In this paper we show that the fragmentation effected by the
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enhanced expression of ssgA results in faster growth in batch
fermentations of several streptomycetes, resulting in shorter
fermentation times and improved productivity.
MATERIALS AND METHODS
Bacterial strains, fermentations, and culturing conditions. The Streptomyces
species described in this paper were S. lividans 1326 and S. coelicolor A3(2)
M145, which were obtained from the John Innes Centre strain collection, and S.
limosus ISP5131 (ATCC 19778), S. rimosus NRRL2234 (ATCC 10970), S. ro-
seosporus NRRL11379 (ATCC 31568), and S. venezuelae ATCC 15439, obtained
from the American Type Culture Collection (ATCC). Modified strains harboring
plasmid pGWS4-SD, which integrates at the C31 attachment site and gives
overproduction of the SsgA protein (21), were designated S. lividans GSAL1 and
S. coelicolor GSA2. Control strains harbored pSET152 (5) without insert.
Larger-scale fermentations were performed in a 42-liter Applikon fermentor.
The defined (minimal) medium, as well as preculturing and inoculation condi-
tions, was described earlier (19), except that glycerol was replaced with an
equimolar amount of glucose. The fermentations were performed at 30°C, and
the pH was controlled at 7.00 by addition of 2 M H2SO4 or 2 M NaOH.
Glutamate utilization was inferred from the acid addition required to neutralize
the released ammonia. To validate our data, the exact glutamate concentration
was determined enzymatically at several time points by use of a glutamate
dehydrogenase-diaphorase–coupled assay (19). The stirrer speed was maintained
at 500 rpm, and the dissolved oxygen tension was kept above 50% by increasing
the overpressure and blending in oxygen in the gas inlet. The inlet and outlet gas
compositions were measured using a VG Gas Prima 600 mass spectrometer.
Small-scale fermentations for the analysis of productivity of modified strepto-
mycetes were performed in a BioFlo 3000 5-liter bench-top fermentor (New
Brunswick Biosciences). Fermentations were performed at 30°C, and the pH was
controlled at 6.7 by the addition of 2 N phosphoric acid or 2 N NaOH. Dissolved
oxygen tension was set at 80% and maintained by changing the stirrer speed. S.
coelicolor M145 and GSA2 were grown in 4 liters of YEME medium (15) without
sucrose, and S. lividans 1326 and GSAL1 harboring pIJ703 (13) were grown in 4
liters of tryptone soy broth with 10% sucrose (TSBS) containing 2.5 g/ml
thiostrepton (to maintain the plasmid) and 25 M CuCl2. All fermentations were
inoculated with 100 ml from a preculture grown in the same medium as the final
broth for 30 h at 30°C in a spring-coiled flask. All fermentations were carried out
three times to ensure reproducibility.
Tyrosinase activity assays. The specific enzymatic activity of tyrosinase se-
creted by transformants of S. lividans 1326 harboring pIJ703 (13) was determined
as described previously, by following the conversion of l-3,4-dihydroxyphenylala-
nine spectrophotometrically (15a) and by determining the biomass content (dry
weight) of the samples.
Antibiotic activity assays. Actinorhodin production by S. coelicolor was deter-
mined as follows. Culture supernatant (4 ml) was treated with 50 l 5 M HCl to
pH 2 to 3, extracted with a 0.5 volume of methanol-chloroform (1:1), and
centrifuged at 5,000 rpm for 10 min. The concentration was calculated from the
A542 (ε542, 18,600). For measurement of undecylpriodigiosin, mycelia were ex-
tracted with methanol and acidified by addition of HCl to a 0.5 M final concen-
tration, and the concentration was calculated from the A530 (ε530, 100,500).
DNA techniques. Streptomyces transformations were performed according to
methods described in reference 15, and selected transformants were checked for
correctness by PCR with Pfu polymerase (Stratagene, La Jolla, CA), according to
methods described in reference 20.
Microscopy. Phase-contrast micrographs were taken with a Zeiss Standard 25
microscope and a high-resolution charge-coupled device camera. Photographs
were processed with Adobe Photoshop CS software.
RESULTS
Effect of SsgA on industrial streptomycetes. Previous work
on the morphological effects of enhanced expression of ssgA
showed that fragmented growth of mycelia was stimulated,
suggesting possible advantages for industrial fermentations
(14, 21). Closer inspection of S. coelicolor GSA2 (which over-
expresses the SsgA protein) by transmission electron micros-
copy revealed a strong increase in septum formation (21). To
assess the potential for growth improvement for industrial fer-
mentations, the effects of the enhanced expression of ssgA on
the morphology, growth, and productivity of streptomycetes
were analyzed. A construct overproducing SsgA was intro-
duced into the model system S. coelicolor A3(2) and the in-
dustrial Streptomyces species S. lividans (the preferred host for
industrial enzyme production), S. limosus (a producer of amy-
lases), S. rimosus (a producer of oxytetracycline), S. roseo-
sporus (a producer of daptomycin), and S. venezuelae (a pro-
ducer of chloramphenicol) (Fig. 1). The reproducible tendency
was that enhanced expression of ssgA resulted in fragmented
growth of strains that normally grow as pellets (S. coelicolor, S.
lividans, and S. roseosporus). Repeated growth measurements
of S. coelicolor and S. lividans (detailed below) and of S. ro-
seosporus (see Fig. S1 in the supplemental material) revealed
that the specific growth rates of the SsgA-modified strains had
increased significantly in comparison to those of the parental
strains. In the case of S. limosus, the parental strain produced
large mycelial mat structures, while the enhanced expression of
ssgA resulted in pellet formation. The effects of the morpho-
logical changes on growth and product formation were not
analyzed. For S. rimosus and S. venezuelae, the parental strain
already grew in a highly fragmented manner (S. rimosus) or
FIG. 1. Effect of SsgA on morphology: representative phase-con-
trast micrographs of mycelia from various streptomycetes with control
plasmid pSET152 (left) or with pGWS4-SD overproducing SsgA
(right). For ATCC strain designations see Materials and Methods.
Notice the strongly reduced pellet formation in S. coelicolor, S.lividans,
and S. roseosporus due to the overexpression of ssgA. Bar, 10 m.
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even sporulated during fermentation (S. venezuelae), and for
both strains we hardly observed mycelia larger than a few
micrometers. Expectedly, SsgA had no noticeable effect on the
morphology of S. rimosus; however, its enhanced expression
prevented the sporulation of S. venezuelae, which is an obvious
advantage under production conditions.
Batch fermentation of S. coelicolor overproducing SsgA.
How do the morphological changes translate to changes in
growth and product formation? To answer this we analyzed
growth rates and productivity of S. coelicolor and S. lividans.
We performed well-controlled batch fermentations on S. coeli-
color M145, genetically the best-characterized actinomycete
and with a known genome sequence (3). The growth-related
problems are a major reason why S. coelicolor has never been
used in large-scale industrial fermentations. We compared S.
coelicolor GSA2 (overproducing SsgA) and its parent M145
harboring control plasmid pSET152. Both strains were first
monitored in well-controlled 25-liter fermentations in defined
minimal medium. While the parental strain produced the typ-
ical large pellets, especially towards the end of the fermenta-
tion, the enhanced expression of ssgA resulted in much smaller
mycelial structures with many protruding hyphae (Fig. 2). Dur-
ing the first 50 h, glutamate was utilized for growth, while
glucose consumption was minimal (Fig. 2). At this stage, the
growth rates of GSA2 and M145/pSET152 were comparable.
The transition from glutamate to glucose is marked by cessa-
tion of the requirement for acid addition (initially required to
neutralize the secreted ammonium produced from glutamate).
After glutamate depletion, growth continued on glucose and
ammonium and production of the pigmented antibiotic acti-
norhodin was induced. The production profile of actinorhodin
was similar in S. coelicolor M145 and GSA2 and, expectedly,
ceased once the glucose was fully consumed. Interestingly, the
growth-optimized strain GSA2 utilized glucose much more
efficiently than M145 (depleting it within 35 h rather than
70 h), resulting in the end of fermentation after 85 h for GSA2
and after 115 h for its parent, M145. We measured and calcu-
lated the specific growth rate (), which was reproducible in
FIG. 2. Effect of enhanced SsgA production on growth of S. coelicolor in a pilot-scale fermentor. Results shown are from batch fermentation
of SsgA-overexpressing S. coelicolor GSA2 (top) and its parent M145, harboring control plasmid pSET152 (bottom), performed in a 42-liter
fermentor. Glutamate was consumed prior to glucose, and glucose consumption started after approximately 50 h. Glutamate concentrations were
calculated from the amount of added acid required to neutralize the ammonia produced from the utilization of glutamate. Growth ceased when
glucose was fully consumed; this was after 85 h for GSA2 and after 115 h for M145 (indicated by arrows). Morphology of the mycelia after
preculturing (pre) and after fermentation (end) is shown in the inset photographs. Clearly visible is the reduced pellet size in the GSA2
transformant. Bar, 20 m.
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several independent fermentations and averaged 0.14 h1 for
S. coelicolor M145 harboring control plasmid pSET152 and
0.20 h1 for the ssgA-modified strain GSA2 in the defined
(minimal) medium, or a 43% increase for GSA2 versus M145.
Hence, the SsgA-induced morphological changes translated to
a significant enhancement of the growth rate.
Subsequently, S. coelicolor GSA2 and M145 were grown in
4-liter batch fermentations in TSBS medium. Cultures were
inoculated from precultures grown for 24 h to a starting bio-
mass of 0.3 g/liter. On average, GSA2 reached a biomass con-
centration of 2.5 g/liter in 3.5 h, compared to 7 h for the same
biomass for the parental strain, M145 (Fig. 3). The specific
growth rate increased by 67%, from 0.33 h1 (M145) to 0.55
h1 (GSA2). While eventually the cultures reached approxi-
mately the same final biomass concentration (25 g [dry weight]/
liter), GSA2 reached the stationary phase after only 7 h, while
M145 control cultures entered the stationary growth phase
after 12 h. In repeated fermentations under the same condi-
tions, the specific growth rate of GSA2 was between 61 and
76% higher than that of the parental M145 strain. Production
of the second pigmented antibiotic undecylprodigiosin reached
a maximum of approximately 5,300 arbitrary units in GSA2
and only around 500 in M145, a difference of an order of
magnitude (Fig. 3).
SsgA enhances growth rate and tyrosinase production by S.
lividans. The morphological engineering technology was then
applied to Streptomyces lividans, the preferred Streptomyces
host for industrial enzyme production. We tested the SsgA-
induced effects of the morphological changes on the yield of
secreted enzymes in 4-liter fermentations in TSBS medium,
using production of the phenoloxidase tyrosinase as the refer-
ence system. Therefore, pIJ703, a plasmid expressing the ty-
rosinase gene melC2 (13), was introduced into S. lividans 1326
and the SsgA-overproducing GSAL1. As expected, enhanced
expression of ssgA altered the morphology of S. lividans, re-
sulting in smaller clumps (Fig. 1). Overproduction of SsgA in S.
lividans had a strongly positive effect on both growth rate and
enzyme production (Fig. 4A and B). This was already apparent
from the initial transformation plates, where colonies of S.
lividans GSAL1 produced much more of the black-pigmented
melanin (the product of the conversion of tyrosine by tyrosi-
nase) than the parental 1326 (Fig. 4A). The observed maxi-
FIG. 3. Effect of enhanced expression of ssgA on growth and anti-
biotic production of S. coelicolor. Batch fermentation of SsgA-overex-
pressing S. coelicolor GSA2 and its parent M145 (with control plasmid
pSET152) was performed in TSBS medium, with control of pH (main-
tained at 6.7) and of dissolved oxygen concentration (maintained at
80%). Biomass accumulation of S. coelicolor M145 (Œ) and GSA2 (●)
was calculated from dry weight measurements, while undecylprodigio-
sin (Red) production (open symbols) was measured spectrophoto-
metrically.
FIG. 4. Effects of enhanced expression of ssgA on growth and ty-
rosinase production of S. lividans. (A) Tyrosinase production by S.
lividans. S. lividans 1326 containing pIJ703 was transformed with
pGWS4-SD (ssgA overproduction; strain GSAL1) or with pSET152
(control plasmid; strain 1326), and transformants were selected on
R2YE agar plates. Representative plates with around 500 colonies are
shown. Note the strongly enhanced tyrosinase production by the SsgA-
overproducing transformant. As follows from the data in panel B, the
SsgA-overproducing strain produced two to three times more tyrosi-
nase than the control strain. Hence, enhanced expression of ssgA
resulted in an important improvement of the tyrosinase yield.
(B) Batch fermentation of SsgA-overproducing S. lividans GSAL1/
pIJ703 and its parent, 1326/pIJ703 (harboring control plasmid
pSET152), was performed in 4 liters of TSBS in a 5-liter fermentor.
The pH was maintained at 6.7, and the dissolved oxygen concentration
was maintained at 80%. Biomass accumulation of S. lividans 1326 (Œ)
and GSAL1 (F) was calculated from dry weight measurements. Ty-
rosinase production (for description of the assay, see Materials and
Methods) is represented by the open symbols.
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mum specific growth rate of S. lividans 1326 increased by 45%
from 0.20 h1 (strain 1326) to 0.29 h1 (GSAL1) (Fig. 4B).
Enzyme production was strongly enhanced, with a maximum
tyrosinase level of 0.94 (relative units) around 20 h after the
start of the fermentation for S. lividans GSAL1, compared to
only 0.55 (relative units) after almost 35 h for the control
strain. This pilot system showed that tyrosinase productivity
(enzyme units/fermentation time) had increased by a factor of
2.5, which points to a strong improvement of productivity.
DISCUSSION
In this paper we established that enhanced fragmentation,
such as that induced by increased expression of ssgA, has a
major impact on growth and product formation by streptomy-
cetes and is therefore expected to have an impact on biotech-
nological applications requiring Streptomyces as the production
host. The morphology of liquid-grown mycelia is dictated by
both external factors (medium and fermentation conditions)
and genetic factors (e.g., the ssgA expression level). For exam-
ple, we have established in many actinomycetes that the degree
of fragmentation (the major determinant of mycelial clump
size) is directly proportional to the frequency of septation (not
shown). This explains why enhanced levels of SsgA, which
stimulates primarily the formation of septa, induce fragmen-
tation. It is likely that controlled fragmentation occurs at the
septa, a process that is stimulated by weakening of the lateral
walls of the vegetative hyphae, e.g., due to an acidic environ-
ment (not shown). Such controlled breakage at septa is advan-
tageous, as here the hypha is divided into two compartments,
each surrounded by a stable cell wall, and hence breakage at
this position results in two viable daughters. In the case of
uncontrolled fragmentation at a different (nonseptal) position,
e.g., due to stirrer-induced mechanical shear, the compartment
will break open, resulting in cell death.
Ideally, precultures should contain fragmented mycelia, so
that the preculture contains a maximal number of growth nu-
clei. This allows low viscosity and optimal transfer of nutrients
and oxygen due to the smaller mycelium size. Studies on eryth-
romycin production by Saccharopolyspora erythraea showed a
striking correlation between mycelium fragment diameter and
productivity for this organism, with a critical fragment size
(close to 100 m) below which productivity was strongly re-
duced (7). Interestingly, selection of variants with reduced
branching rates and enhanced strength of the cell wall resulted
in significantly enhanced production (23). It is unclear how
these observations translate to other production processes
(e.g., enzymes), as antibiotic production is often strongly
growth phase dependent (4).
An obvious and important question that we addressed in this
work is, how does fragmentation translate to the production
process, i.e., growth rate and yield of product formation? In-
terestingly, we observed that enhanced expression of ssgA in S.
coelicolor, S. lividans, and S. roseosporus resulted in improved
growth rates, with a reduced lag phase and a smaller average
mycelium size. In 25-liter batch fermentations with a defined
minimal medium, the specific growth rate increased from 0.14
h1 to 0.20 h1, a 43% increase. This positive effect on growth
rate was confirmed by the 4-liter batch fermentations, where
enhancement of the specific growth rate by the overexpression
of ssgA was 67% (0.33 h1 to 0.55 h1) for S. coelicolor M145
and 45% (0.20 h1 to 0.29 h1) for S. lividans 1326. The
differences in growth rates between 25-liter and 4-liter fermen-
tations are explained by the media used (minimal versus rich).
Eventually, cultures reached the same total biomass, but the
obvious advantage was that for ssgA-modified strains the fer-
mentation time was at least halved with respect to that re-
quired for the control strain. S. lividans is an important com-
mercial strain, as it is used as the preferred Streptomyces host
for enzyme production. Our pilot system showed that tyrosi-
nase productivity (enzyme units/fermentation time) had in-
creased by a factor of 2.5, which promises strong improvement
of productivity. In a recent publication it was shown that also
multiple copies of the AraC-type transcriptional regulator
AdpA effect improved tyrosinase production (26). Most likely
this also relates to the activity of SsgA, since AdpA is the
transcriptional activator of ssgA in S. griseus (24). Besides the
effect on enzyme production/secretion by S. lividans, in cul-
tures of S. coelicolor GSA2 we observed a strong increase in
undecylprodigiosin production (approximately 10-fold). How-
ever, actinorhodin production was somewhat reduced in the
modified strain. The latter is explained by the rapid consump-
tion of glucose by GSA2 in the final growth phase in compar-
ison to the slower-growing parental strain.
In conclusion, the enhanced expression of ssgA may prove an
efficient means for the directed strain improvement of actino-
mycetes that are difficult to cultivate, while the more frag-
mented growth also makes growth in microtiter plates much
more feasible and an important issue for high-throughput
screening. Streptomycetes produce a wealth of natural prod-
ucts, both secondary metabolites and enzymes, and the appli-
cation of SsgA as a means to improve their growth and pro-
ductivity will possibly make them a more attractive alternative
to currently used commercial production hosts. Besides these
attractive cost-related aspects, the reduced energy requirement
offers new means in the battle for more sustainable production
solutions.
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